EX-24.1 4 d942180dex241.htm EX-24.1 EX-24.1

Exhibit 24.1

LABCORP HOLDINGS INC.

S- 8 Power of Attorney

KNOW ALL BY THESE PRESENTS, that each of the undersigned officers and directors of Labcorp Holdings Inc., a Delaware corporation (the “Corporation”), hereby constitutes and appoints Adam H. Schechter, Julia A. Wang and Sandra D. van der Vaart, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution and full power to act without the other, for him or her and in his or her name, place and stead, in any and all capacities, to sign the registration statements on Forms S-8 (the “Registration Statements”) of the Corporation relating to securities of the Corporation acquired under or to be offered under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan or the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan, and any and all amendments (including post-effective amendments) or supplements to the Registration Statements, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their substitutes, may lawfully do or cause to be done by virtue hereof.

This Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original with respect to the individual executing it.

 

Name and Title

 

Date

/s/ Adam H. Schechter

  May 27, 2025

Adam H. Schechter

Chairman of the Board, President,

Chief Executive Officer and Director

 

/s/ Julia A. Wang

  May 28, 2025

Julia A. Wang

Executive Vice President, Chief Financial Officer

 

/s/ Peter J. Wilkinson

  May 28, 2025

Peter J. Wilkinson

Senior Vice President, Chief Accounting Officer

 

/s/ Kerrii B. Anderson

  May 27, 2025

Kerrii B. Anderson

Director

 

/s/ Jeffrey A. Davis

  May 26, 2025

Jeffrey A. Davis

Director

 

/s/ D. Gary Gilliland

  May 27, 2025

D. Gary Gilliland, M.D., Ph.D.

Director

 

/s/ Kirsten M. Kliphouse

  May 22, 2025

Kirsten M. Kliphouse

Director

 

/s/ Garheng Kong

  May 22, 2025

Garheng Kong, M.D., Ph.D.

Director

 

/s/ Peter M. Neupert

  May 23, 2025

Peter M. Neupert

Director

 


/s/ Richelle P. Parham

  May 22, 2025

Richelle P. Parham

Director

 

/s/ Paul B. Rothman

  May 22, 2025

Paul B. Rothman, M.D.

Director

 

/s/ Kathryn E. Wengel

  May 22, 2025

Kathryn E. Wengel

Director